| 000 | 01181 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515073914.0 | ||
| 264 | 0 | _c20070913 | |
| 008 | 200709s 0 0 ger d | ||
| 022 | _a1438-3276 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScholze, J | |
| 245 | 0 | 0 |
_a[Blood pressure lowering and risk reduction under treatment with valsartan and its combination with hydrochlorothiazide (HCT)]. _h[electronic resource] |
| 260 |
_bMMW Fortschritte der Medizin _cOct 2006 |
||
| 300 |
_a48 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadverse effects |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xprevention & control |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrochlorothiazide _xadverse effects |
| 650 | 0 | 4 |
_aHypertension _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTetrazoles _xadverse effects |
| 650 | 0 | 4 |
_aValine _xadverse effects |
| 650 | 0 | 4 | _aValsartan |
| 700 | 1 | _aMüller, U | |
| 773 | 0 |
_tMMW Fortschritte der Medizin _gvol. 148 _gno. 42 _gp. 48 |
|
| 999 |
_c17157136 _d17157136 |
||